decide Clinical Software develops and provides AI-driven, safe, fast and evidence-based dosing of insulin at the point of care for seriously ill inpatients via our Clinical Decision Support System GlucoTab.
As a medical technology company based in Austria, A.M.I. Agency for Medical Innovations has been engaged in the development and production of medical innovations and surgical solutions in the fields of Coloproctology, Urology and Urogynecology for over 20 years. With high quality products, A.M.I. contributes to improving surgical procedures and enhancing patients’ quality of life. The foundation for this is the maximum quality standards and the goal of achieving perfection of the product.
At SteadySense, we are using sensor technology in the global femtech fertility industry as well as creating diagnostic tools used in the early detection of infections utilising the enormous potential of sensor technology and continuous temperature measurement in the areas of medicine, healthcare and industry.
AVVie GmbH is developing a novel minimally invasive implant aimed at addressing a prolific heart valve condition affecting millions worldwide.
telbiomed specialises in the distribution of digital software platforms for health services. We design, implement and maintain the KeepInTouch (KIT) telehealth software of AIT Austrian Institute of Technology GmbH for healthcare providers, health insurers and pharmaceutical customers. We provide our customers with turnkey telehealth solutions that facilitate the collection of health data and the coordinated collaboration of all stakeholders: doctors, nurses, therapists, patients and care manager
Lung-Diagnostics GmbH develops intelligent measuring, a novel device and diagnosis software based on artificial intelligence for faster and reliable diagnosis of dysfunctions of the respiratory track for better lung health and personalized treatments.
medPhoton develops modern high-end technologies for image guided procedures in radiotherapy and surgery.
The achievement of Heart Regeneration Technologies is to refine low-energy regenerative shockwave therapy. Shockwaves at low energy levels exert regenerative effects rather than disintegration of stones or plaques such as with high energies in Lithotripsie. We developed a sterile applicator suitable for direct cardiac application during heart surgery. Our hand-held applicator is the world’s smallest shockwave applicator and there are many ideas in the pipeline.
Cube Dx is located in St. Valentin (Austria). Cube Dx entirely new multiplex technology - the hybcell – is the world's first cylindrical microarray – delivers speedy and reliable results with minimal effort. The hyborg – a completely automated device – processes the samples fully independently and without any intervention by the user. The Cube Dx assay is based on compact sequencing and is designed to address especially those complex diagnostic challenges where fast answers are essential.
For about 20 years, the Research Department Medical Informatics of RISC Software GmbH has been successfully developing highly specialized software for modern medicine. The research department is very well connected regionally, nationally, and internationally. It has a lot of experience in the management and implementation of collaborative research projects with partners from industry, science, and medicine. The scope of activity ranges from basic research to clinically applicable software.